COG ACNS1721: Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed high-grade glioma without H3 K27M or BRAF mutations Meeting Abstract


Authors: Karajannis, M.; Thomas, A. O.; Baxter, P.; Butingan, N.; Fuller, C.; Gajjar, A.; Haque, S.; Jabado, N.; Lin, T.; Lucas, J.; MacDonald, S.; Matsushima, C.; Patel, N.; Pierson, C.; Springer, L.; Stark, E.; Souweidane, M.; Walsh, M.; Zaky, W.; Fouladi, M.; Cohen, K.
Abstract Title: COG ACNS1721: Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed high-grade glioma without H3 K27M or BRAF mutations
Meeting Title: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO)
Journal Title: Neuro-Oncology
Volume: 24
Issue: Suppl. 7
Meeting Dates: 2022 Nov 16-20
Meeting Location: Tampa Bay, FL
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2022-11-01
Start Page: vii78
Language: English
ACCESSION: WOS:000888571000299
PROVIDER: wos
DOI: 10.1093/neuonc/noac209.296
Notes: Meeting Abstract: CTNI-31 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors